JDD Highlights

The Latest on Oncodermatology, Psoriasis, Atopic Dermatitis & More

Dermatology News

JDD Highlights

The May issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin Cancer, with special features on Public Health, Atopic Dermatitis, Psoriasis, and more.

Read the JDD Now

Oncodermatology, Psoriasis, Atopic Dermatitis & More

The May issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin Cancer, with special features on Public Health, Atopic Dermatitis, Psoriasis, and more.

Article Highlights

Editor's Picks

Aesthetics

You May Also Like

Journal of Drugs in Dermatology JDD Article about The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma PatientsFeatured ArticlesLatest NewsSkin Cancer
December 15, 2025

The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

From the Vault: Fecal transplant may revive immunotherapy responses in melanoma We pulled this February 2024 vault article because it’s been a popular read. It’s a focused review of microbiota‑modulating…
Journal of Drugs in Dermatology JDD Article about GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its ComorbiditiesFeatured ArticlesHidradenitis SuppurativaLatest News
December 14, 2025

GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

Metabolic drugs for HS? GLP‑1 receptor agonists show promise beyond weight loss If you haven’t yet, dig into this recent JDD article about GLP-1 receptor agnosists and hidradenitis suppurativa. Hidradenitis…
AcneFeatured ArticlesLatest NewsMedical Derm
December 11, 2025

Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis

Isotretinoin and IBD — large real‑world data offer reassurance In one of our recent JDD articles, a retrospective cohort using the TriNetX network compared acne patients exposed to long‑term, low‑dose…

Leave a Reply